News Roundup [abridged Versions Appear In The Paper Journal]

Drug chiefs ponder how to improve industry's reputation

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7502.1229-a (Published 26 May 2005) Cite this as: BMJ 2005;330:1229
  1. Bob Burton
  1. Canberra

    Drug industry executives and advisers told a conference in Sydney last week that the poor public standing of the industry was hindering its ability to sell its products at higher prices to government agencies as well as its attempts to address public criticism.

    Introducing a panel discussion on reputation management, Kristin Austin, director of the public relations company Ruder Finn, said that a review of coverage of the industry in the Sydney print media showed 30 positive stories in the preceding year but 40 critical stories.

    “Each negative story requires six …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe